Items of recent pandemic news you may have missed: Delta Air Lines’ strong encouragement for vaccination; contaminated vaccine in Japan; good news on a J&J booster; and the dent approval is not making in vaccine hesitancy. Plus two fripperies. Approval … Continue reading →
Items of recent pandemic news: Is the FDA moving too fast or too slow? Flying blind on delta breakthrough data; an early hint that boosters do what was hoped; and full FDA approval for Pfizer / BioNTech. Plus a frippery. … Continue reading →
Items of recent pandemic news: China will donate 2 billion doses; the unvaxxed consider shots more dangerous than Covid-19; FDA is fast-tracking full approval for Pfizer; countries and the WHO weigh booster shots; and more. Plus a frippery. 1. Pfizer … Continue reading →
Items of recent pandemic news you may have missed: Too much testing of asymptomatic immune people? The new risk calculus of the delta variant, the coming mitigations, the anatomy of why delta spreads so fast, and more. Plus a frippery. … Continue reading →
Herewith three items of pandemic news you may have missed recently: Youyang Gu’s model of the path to herd immunity; hesitancy from several directions about Johnson & Johnson’s vaccine; and the latest on pandemic passports. Plus news briefs and a … Continue reading →
Herewith three items of pandemic news you may have missed recently: Controlling the message on vaccines of different efficacy; Johnson & Johnson’s day in the spotlight; and media jumping the gun on viral variant stories. Plus news briefs and a … Continue reading →
Herewith three items of pandemic news you may have missed recently: More on virus variants; Novavax’s Phase III study is leaking volunteers; and vaccine hesitancy in the Black population. Plus news briefs and a frippery. Black vaccine hesitancy For all … Continue reading →
